Quick filters:
Open Data
Open Code
Pre-registered
Funding Declared
COI Declared
Open Access
Clear Filters
Peroxisomal β-oxidation enzyme, DECR2, regulates lipid metabolism and promotes treatment resistance in advanced prostat…
Mah CY; Nguyen ADT; Niijima T; Helm M; Dehairs J; Ryan FJ; Ryan N; Quek LE; Hoy AJ; Don AS; Mills IG; Swinnen JV; Lynn DJ; Nassar ZD; Butler LM.
Br J Cancer
(Unknown)
Published: 2024
Phase 1 study of high-dose DFMO, celecoxib, cyclophosphamide and topotecan for patients with relapsed neuroblastoma: a …
Hogarty MD; Ziegler DS; Franson A; Chi YY; Tsao-Wei D; Liu K; Vemu R; Gerner EW; Bruckheimer E; Shamirian A; Hasenauer B; Balis FM; Groshen S; Norris MD; Haber M; Park JR; Matthay KK; Marachelian A.
Br J Cancer
(Unknown)
Published: 2024
Autoantibodies, antigen-autoantibody complexes and antigens complement CA125 for early detection of ovarian cancer.
Young Han C; Bedia JS; Yang WL; Hawley SJ; Bergan L; Hopper M; Celestino J; Guo J; Gornet TG; Soosaipillai A; Yang H; Doskocil SD; Lokshin AE; Handy BC; Diamandis EP; Moore RG; Lu KH; Lu Z; Anderson KS; Drescher CW; Skates SJ; Bast RC.
Br J Cancer
(Unknown)
Published: 2024
Targeting serine/glycine metabolism improves radiotherapy response in non-small cell lung cancer.
Sánchez-Castillo A; Heylen E; Hounjet J; Savelkouls KG; Lieuwes NG; Biemans R; Dubois LJ; Reynders K; Rouschop KM; Vaes RDW; De Keersmaecker K; Lambrecht M; Hendriks LEL; De Ruysscher DKM; Vooijs M; Kampen KR.
Br J Cancer
(Unknown)
Published: 2023
The impact of circulating protein levels identified by affinity proteomics on short-term, overall breast cancer risk.
Grassmann F; Mälarstig A; Dahl L; Bendes A; Dale M; Thomas CE; Gabrielsson M; Hedman ÅK; Eriksson M; Margolin S; Huang TH; Ulfstedt M; Forsberg S; Eriksson P; Johansson M; Hall P; Schwenk JM; Czene K.
Br J Cancer
(Unknown)
Published: 2023
NCI10066: a Phase 1/2 study of olaparib in combination with ramucirumab in previously treated metastatic gastric and ga…
Cecchini M; Cleary JM; Shyr Y; Chao J; Uboha N; Cho M; Shields A; Pant S; Goff L; Spencer K; Kim E; Stein S; Kortmansky JS; Canosa S; Sklar J; Swisher EM; Radke M; Ivy P; Boerner S; Durecki DE; Hsu CY; LoRusso P; Lacy J.
Br J Cancer
(Unknown)
Published: 2023
Discordance between GCIG CA-125 progression and RECIST progression in the CALYPSO trial of patients with platinum-sensi…
Zebic DS; Tjokrowidjaja A; Francis KE; Friedlander M; Gebski V; Lortholary A; Joly F; Hasenburg A; Mirza M; Denison U; Cecere SC; Ferrero A; Pujade-Lauraine E; Lee CK.
Br J Cancer
(Unknown)
Published: 2023
Observational and genetic associations between cardiorespiratory fitness and cancer: a UK Biobank and international con…
Watts EL; Gonzales TI; Strain T; Saint-Maurice PF; Bishop DT; Chanock SJ; Johansson M; Keku TO; Le Marchand L; Moreno V; Newcomb PA; Newton CC; Pai RK; Purdue MP; Ulrich CM; Smith-Byrne K; Van Guelpen B; PRACTICAL consortium; CRUK; BPC3; CAPS; PEGASUS; Day FR; Wijndaele K; Wareham NJ; Matthews CE; Moore SC; Brage S.
Br J Cancer
(Unknown)
Published: 2023
Apalutamide efficacy, safety and wellbeing in older patients with advanced prostate cancer from Phase 3 randomised clin…
Shen J; Chowdhury S; Agarwal N; Karsh LI; Oudard S; Gartrell BA; Feyerabend S; Saad F; Pieczonka CM; Chi KN; Brookman-May SD; Rooney B; Bhaumik A; McCarthy SA; Bevans KB; Mundle SD; Small EJ; Smith MR; Graff JN.
Br J Cancer
(Unknown)
Published: 2023
Integrating a microRNA signature as a liquid biopsy-based tool for the early diagnosis and prediction of potential ther…
Shi W; Wartmann T; Accuffi S; Al-Madhi S; Perrakis A; Kahlert C; Link A; Venerito M; Keitel-Anselmino V; Bruns C; Croner RS; Zhao Y; Kahlert UD.
Br J Cancer
(Unknown)
Published: 2023
Targeting the COMMD4-H2B protein complex in lung cancer.
Tang M; Burgess JT; Fisher M; Boucher D; Bolderson E; Gandhi NS; O'Byrne KJ; Richard DJ; Suraweera A.
Br J Cancer
(Unknown)
Published: 2023
Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adeno…
Jo JH; Kim YT; Choi HS; Kim HG; Lee HS; Choi YW; Kim DU; Lee KH; Kim EJ; Han JH; Lee SO; Park CH; Choi EK; Kim JW; Cho JY; Lee WJ; Moon HR; Park MS; Kim S; Song SY.
Br J Cancer
(Unknown)
Published: 2023
Phase II study of everolimus and temozolomide as first-line treatment in metastatic high-grade gastroenteropancreatic n…
Morken S; Langer SW; Sundlöv A; Vestermark LW; Ladekarl M; Hjortland GO; Svensson JB; Tabaksblat EM; Haslerud TM; Assmus J; Detlefsen S; Couvelard A; Perren A; Sorbye H.
Br J Cancer
(Unknown)
Published: 2023